Back to Treatments

Treatment

Dabrafenib + Trametinib

1
Conditions
18
Trials
5,000
Participants
38%
Average Safety

Condition Evidence

Malignant skin melanoma

18 trials · 5,000 participants

91% effectiveness · 38% safety
Dabrafenib + Trametinib | DFDA